WA
ABBV icon

Wheatland Advisors’s AbbVie ABBV Stock Holding History

Wheatland Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$236K Buy
+2,404
New +$212K 0.98% 35
2020
Q1 		– Sell
-6,417
Closed -$568K – 38
2019
Q4 		$568K Sell
6,417
-1,196
-16% -$99.3K 0.72% 50
2019
Q3 		$576K Buy
7,613
+7
+0.1% +$480 0.52% 63
2019
Q2 		$553K Buy
7,606
+51
+0.7% +$4.01K 0.42% 68
2019
Q1 		$609K Buy
7,555
+5
+0.1% +$409 0.46% 63
2018
Q4 		$696K Buy
7,550
+3
+0% +$264 0.61% 55
2018
Q3 		$714K Buy
7,547
+4
+0.1% +$379 0.54% 59
2018
Q2 		$699K Buy
7,543
+3
+0% +$293 0.56% 58
2018
Q1 		$714K Buy
7,540
+2
+0% +$220 0.59% 56
2017
Q4 		$729K Buy
7,538
+2
+0% +$188 0.59% 54
2017
Q3 		$670K Buy
7,536
+3
+0% +$228 0.57% 57
2017
Q2 		$546K Buy
7,533
+3
+0% +$202 0.49% 61
2017
Q1 		$491K Sell
7,530
-21
-0.3% -$1.32K 0.44% 65
2016
Q4 		$473K Buy
7,551
+3
+0% +$183 0.42% 66
2016
Q3 		$476K Buy
7,548
+3
+0% +$194 0.45% 61
2016
Q2 		$467K Sell
7,545
-197
-3% -$12K 0.45% 60
2016
Q1 		$442K Sell
7,742
-497
-6% -$27.7K 0.45% 60
2015
Q4 		$488K Buy
8,239
+3
+0% +$173 0.5% 60
2015
Q3 		$448K Buy
8,236
+2
+0% +$130 0.49% 61
2015
Q2 		$553K Buy
8,234
+2
+0% +$131 0.53% 60
2015
Q1 		$482K Buy
8,232
+3
+0% +$181 0.48% 61
2014
Q4 		$539K Buy
8,229
+2
+0% +$126 0.53% 60
2014
Q3 		$475K Buy
8,227
+2
+0% +$111 0.47% 62
2014
Q2 		$464K Hold
8,225
– – 0.42% 67
2014
Q1 		$423K Sell
8,225
-100
-1% -$5.05K 0.43% 63
2013
Q4 		$440K Buy
+8,325
New +$409K 0.46% 62

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Wheatland Advisors's ABBV Position: Q2 2020 in Review

Wheatland Advisors opened a new position in AbbVie (ABBV) in Q2 2020: 2,404 shares worth $236K. The stake represents 0.98% of the portfolio and ranks #35 among its holdings. This is a return to the name: Wheatland Advisors previously reported a position in ABBV as recently as Q4 2019.

Wheatland Advisors first reported a position in ABBV in Q4 2013 and has held it in 26 quarters since. The position peaked at $729K in Q4 2017. 2,411 funds tracked by Wall St. Rank hold ABBV as of Q2 2020.

  • Wheatland Advisors held 2,404 shares of AbbVie worth $236K as of Q2 2020.
  • AbbVie was a new Wheatland Advisors position in Q2 2020.
  • AbbVie made up 0.98% of Wheatland Advisors's portfolio in Q2 2020, its #35 holding.
  • Wheatland Advisors first reported a position in AbbVie in Q4 2013 and has held it in 26 quarters since.
  • Wheatland Advisors's AbbVie position peaked at $729K in Q4 2017.
  • 2,411 funds tracked by Wall St. Rank held AbbVie as of Q2 2020.

Based on Wheatland Advisors's 13F filing for Q2 2020, filed 28 Jul 2020.